天猫电商运营中，商家常面临选择：是与天猫代运营合作，还是自建团队？两者各有特点，而代运营凭借多维度优势，成为不少商家的选项。深入了解代运 营的核心优势，并结合自身情况对比分析，才能做出更适合的决策。 一、天猫代运营的核心优势 1. 专业能力更突出 天猫代运营机构长期深耕电商领域，对平台规则、算法变化、行业趋势有着更敏锐的洞察和更深入的理解。其团队成员多由经验丰富的运营、设计、营销、 客服等专业人员组成，能熟练掌握各类运营技巧，比如精准的流量投放策略、高效的转化优化方法、系统的用户维护体系等。相比之下，商家若从零开始搭 建团队，成员往往缺乏实战经验，需要较长时间摸索，难以快速跟上平台节奏，可能错过市场机遇。 2. 资源整合更高效 选择代运营，商家无需承担团队招聘、培训、薪资福利、办公场地租赁、设备采购等固定成本，只需按照合作协议支付服务费用，成本投入更灵活可控。且 代运营会根据商家需求精准分配资源，避免不必要的成本浪费。自建团队则需承担高额的固定成本，即便店铺运营初期业绩不佳，这些成本也无法减少，会 给商家带来较大的资金压力。 4. 运营效率更高效 代运营团队有着成熟的运营流程和完善的协作机制，能快速响应市场变 ...

Core Viewpoint - The company is focused on improving its cash flow and profitability through various strategic initiatives, including cost control, business transformation, and leveraging acquisitions to enhance its operational capabilities [1][2]. Group 1: Financial Performance - In the first half of 2025, the company's net cash flow from operating activities was -546 million yuan, a significant improvement from -743 million yuan in the same period last year, indicating a narrowing of cash outflow [1]. - The company aims to strengthen accounts receivable management and optimize inventory structure to further enhance cash flow [1]. Group 2: Business Strategy - The company is committed to transforming its core profitability by implementing lean management practices, optimizing sales strategies, and reducing costs through centralized procurement and capacity integration in its industrial sector [1]. - The company has initiated a systematic approach to product development, with 12 industrial products launched, 10 submitted for approval, and 10 approved in the first half of the year, alongside 17 patent applications [1]. Group 3: Acquisition and Synergy - The company has completed the acquisition of 100% equity in Jinsui Technology, which is expected to create synergies with its existing pharmaceutical and industrial businesses [1][2]. - Jinsui Technology's established e-commerce operations and marketing expertise will support the company's transition from a pharmaceutical enterprise to a health-focused enterprise, enhancing its capabilities in e-commerce platform development and brand building [2].

Core Viewpoint - The Hong Kong capital market is experiencing a strong recovery in IPO activities, with a total fundraising of HKD 107.1 billion in the first half of 2025, a sevenfold increase compared to the same period last year, making it the highest globally and the second highest in nearly a decade [1] Company Overview - Suzhou Jiyi Technology Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor [1] - Jiyi Technology is a leading digital retail comprehensive operation service provider and a Silk Road e-commerce service provider in China, focusing on brand asset management driven by AI and digital intelligence [1] Financial Performance - Jiyi Technology's revenue and profit have shown overall growth, with revenues of approximately RMB 1.117 billion, RMB 1.356 billion, and RMB 1.4 billion for the years 2022, 2023, and 2024 respectively, and annual profits of RMB 37.58 million, RMB 24.87 million, and RMB 49.82 million during the same periods [1][3] - The company's GMV increased from RMB 8.2 billion in 2022 to RMB 11.1 billion in 2023, and further to RMB 15 billion in 2024, reflecting a growth rate of 35.1% and 35.3% respectively [2] Business Segmentation - Jiyi Technology has diversified its revenue structure, with three main business segments: brand-to-consumer solutions, brand-to-business solutions, and brand asset management [4] - The core business, brand-to-consumer solutions, saw its revenue share decrease from 88.5% in 2022 to 60.2% in 2024, while brand-to-business solutions increased from 5.7% to 35.3% during the same period [4] Profitability Analysis - The gross margin for brand-to-consumer solutions increased from 17.8% to 18.4% from 2022 to 2024, while brand-to-business solutions' gross margin rose from 3.0% to 5.4% [5] Technological Advancements - Jiyi Technology has developed a self-researched multimodal heterogeneous computing engine platform for AI, enabling smart content generation and precise marketing recommendations [6] Industry Trends - The e-commerce industry is entering a phase of stable growth, with a 7.2% increase in online retail sales in 2024, and the cross-border e-commerce market continues to expand, reaching RMB 17.66 trillion [7][10] - The shift from online platforms to offline retail is in line with industry trends, as the offline retail market showed a significant recovery with a growth rate of 13.6% in 2024 [10][11]

Group 1 - The core viewpoint of the article is that Suzhou Jiyi Technology Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, positioning itself as a leading digital retail comprehensive operation service provider in China, with significant rankings in both digital retail and e-commerce operation sectors [1][2]. - Jiyi Technology ranks second among digital retail comprehensive operation service providers in China and fifth among e-commerce operation service providers based on GMV for 2024, according to Frost & Sullivan data [1]. - The company has established a strong brand value chain service capability, collaborating with over 200 global brands across various categories, including health, beauty, fast-moving consumer goods, home, and appliances [1]. Group 2 - Financial data indicates steady revenue growth for Jiyi Technology, with GMV increasing from 8.2 billion RMB in 2022 to 11.1 billion RMB in 2023, and further to 15.0 billion RMB in 2024, representing growth rates of 35.1% and 35.3% respectively [2]. - Revenue figures for the years 2022, 2023, and 2024 are 1.117 billion RMB, 1.356 billion RMB, and 1.400 billion RMB, respectively, while the gross profit margin has declined from 17.4% in 2022 to 14.4% in 2024 [2]. - Net profit for the years 2022, 2023, and 2024 is reported as 37.58 million RMB, 24.87 million RMB, and 49.82 million RMB, showing a significant drop in 2023 but a recovery in 2024 [2]. Group 3 - The company faces challenges such as high customer concentration, with revenue from the top five customers accounting for 77.3%, 58.7%, and 56.2% of total revenue in 2022, 2023, and 2024, respectively [2]. - The reliance on major e-commerce platforms is a critical risk factor, as the business model heavily depends on maintaining relationships with these platforms [3]. - Regulatory changes and specific risks associated with international and cross-border e-commerce operations are additional challenges that the company must navigate [3].

Core Insights - The article highlights the growth and positioning of the company, Jiyi Technology, as a leading digital retail comprehensive operation service provider in China, focusing on AI-driven brand asset management and cross-border e-commerce services [3][4]. Company Overview - Jiyi Technology is recognized as the second-largest digital retail comprehensive operation service provider in China and the fifth-largest e-commerce operation service provider based on GMV projections for 2024 [3]. - The company ranks first among cross-border import e-commerce operation service providers in China according to GMV for 2024 [3]. Financial Performance - The company's GMV increased from 8.2 billion RMB in 2022 to 11.1 billion RMB in 2023, representing a growth of 35.1%, and is projected to reach 15 billion RMB in 2024, further increasing by 35.3% [4]. - Revenue figures for the years 2022, 2023, and 2024 are approximately 1.12 billion RMB, 1.36 billion RMB, and 1.4 billion RMB respectively [4][6]. - The company reported annual profits of approximately 37.6 million RMB in 2022, 24.9 million RMB in 2023, and 49.8 million RMB in 2024 [4][6]. Service Capabilities - Jiyi Technology has established partnerships with over 200 global brands across various sectors, including health, beauty, fast-moving consumer goods, home, and appliances [3]. - The company provides digital retail comprehensive operation services to major supermarkets, assisting traditional retailers in integrating online and offline channels [3]. Market Positioning - The company has transitioned from a traffic-oriented e-commerce operation model to a consumer demand-driven model, focusing on product innovation and consumer scenario construction [4].

Core Viewpoint - China National Pharmaceutical Group plans to acquire 100% equity of Beijing Jinsui Technology Development Co., Ltd. for 302 million yuan, aiming to enhance its e-commerce capabilities and transition from a pharmaceutical company to a health enterprise [1][2][5] Group 1: Acquisition Details - The acquisition involves a cash payment of 302 million yuan for the full ownership of Jinsui Technology, which operates in the e-commerce service industry [1][2] - Jinsui Technology's core business includes brand authorization and distribution of Philips personal health consumer products, with a significant presence on major e-commerce platforms [2][3] - The transaction is classified as a related party transaction since Jinsui Technology is a subsidiary of the controlling shareholder of China National Pharmaceutical [2] Group 2: Financial Performance of Jinsui Technology - Jinsui Technology's revenue has declined significantly from 1.747 billion yuan in 2021 to 1.018 billion yuan in 2023, representing a nearly 40% decrease over two years [1][3] - The company's net profit also showed a downward trend, with figures of 46.13 million yuan in 2021 dropping to 21.36 million yuan in 2024 [3] - As of early 2025, Jinsui Technology had outstanding loans totaling 205 million yuan owed to its parent company, with interest payments of approximately 2.58 million yuan in the first quarter of 2025 [6][7] Group 3: China National Pharmaceutical's Financial Performance - In 2024, China National Pharmaceutical reported a revenue of 34.148 billion yuan, a decrease of 12.04% year-on-year, and a net profit of 535 million yuan, down 48.91% [5][6] - The company's three main business segments—pharmaceutical manufacturing, pharmaceutical commerce, and international trade—experienced revenue declines of 9.85%, 9.72%, and 41.82% respectively [6] - In the first quarter of 2025, the company achieved a revenue of 8.263 billion yuan, reflecting a year-on-year decline of 5.84% [6]

Core Viewpoint - China National Pharmaceutical Group plans to acquire 100% equity of Jinsui Technology for 302 million yuan, which constitutes a related party transaction [1] Group 1: Acquisition Details - The acquisition will be conducted in cash amounting to 302 million yuan [1] - Jinsui Technology will become a wholly-owned subsidiary of China National Pharmaceutical Group after the transaction [1] - The seller, New Star Group, is a wholly-owned subsidiary of the controlling shareholder, General Technology Group [1] Group 2: Business Operations - Jinsui Technology specializes in e-commerce operation services, covering personal health consumer products and the broader health sector [1] - The company has established partnerships with well-known domestic and international brands such as Philips and Omron [1] - The core business currently focuses on brand authorization and distribution of Philips personal health consumer products [1]